What is the recommended management for pericarditis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 18, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Management of Pericarditis

First-line treatment for pericarditis consists of aspirin or NSAIDs plus colchicine, with therapy guided by symptom resolution and CRP normalization. 1

Diagnosis

Acute pericarditis is diagnosed when at least 2 of the following 4 criteria are present:

  • Sharp, pleuritic chest pain that worsens when supine (~90% of cases) 2
  • New widespread ST-segment elevation and PR depression on ECG (~25-50% of cases) 2
  • New or increased pericardial effusion (~60% of cases) 2
  • Pericardial friction rub (<30% of cases) 2

Risk Stratification

Patients should be triaged based on risk factors:

High-risk features (requiring hospitalization):

  • Fever >38°C
  • Subacute onset
  • Large pericardial effusion
  • Cardiac tamponade
  • Failure to respond to NSAIDs after at least 1 week
  • Immunosuppression
  • Trauma
  • Oral anticoagulant therapy
  • Myopericarditis with troponin elevation

Low-risk features (outpatient management):

  • Absence of high-risk features
  • Good response to NSAIDs

Treatment Algorithm

1. Acute Pericarditis (First Episode)

First-line therapy:

  • NSAIDs:
    • Ibuprofen 600mg every 8 hours (1200-2400mg/day) for 1-2 weeks 1
    • OR Aspirin 750-1000mg every 8 hours (1500-3000mg/day) for 1-2 weeks 1
    • Always with gastroprotection
  • PLUS Colchicine:
    • 0.5mg twice daily if ≥70kg
    • 0.5mg once daily if <70kg or intolerant to higher doses
    • Continue for 3 months 1

Tapering:

  • Decrease NSAID/aspirin doses gradually after symptom resolution and CRP normalization
  • Ibuprofen: decrease by 200-400mg every 1-2 weeks 1
  • Aspirin: decrease by 250-500mg every 1-2 weeks 1

Second-line therapy (only if contraindication/failure of first-line):

  • Low-dose corticosteroids (prednisone 0.2-0.5mg/kg/day) 1
  • Only after excluding infectious causes
  • Maintain initial dose until symptoms resolve and CRP normalizes, then taper

2. Recurrent Pericarditis

Recurrence is defined as return of symptoms after a symptom-free interval of at least 4-6 weeks 1

First-line therapy:

  • Same as acute pericarditis but with longer colchicine duration (6 months) 1, 2

Second-line therapy:

  • Low-dose corticosteroids if NSAIDs and colchicine fail or are contraindicated 1

Third-line therapy (for multiple recurrences):

  • Immunoglobulin, anakinra, or azathioprine 1, 3

Fourth-line therapy:

  • Pericardiectomy (last resort) 1

Special Considerations

Myopericarditis

  • Hospitalization required for diagnosis and monitoring 1
  • Coronary angiography recommended to rule out acute coronary syndromes 1
  • CMR recommended to confirm myocardial involvement 1
  • Rest and avoidance of physical activity for 6 months 1
  • Anti-inflammatory therapy at lowest effective doses 1

Exercise Restrictions

  • Non-athletes: Restrict until symptom resolution and normalization of CRP, ECG, and echocardiogram 1
  • Athletes: Restrict for at least 3 months and until normalization of all parameters 1

Monitoring and Follow-up

  • Use CRP to guide treatment duration and assess response 1
  • Continue therapy until complete symptom resolution and CRP normalization 1
  • Follow-up echocardiogram to assess for effusion resolution
  • Monitor for complications (tamponade, constrictive pericarditis)

Complications and Prognosis

  • Most patients with idiopathic/viral pericarditis have good long-term prognosis 1
  • Recurrence rate: 15-30% without colchicine, reduced to about 16.7% with colchicine 1, 2
  • Risk of constrictive pericarditis: <1% in idiopathic cases, higher (20-30%) in bacterial etiologies 1
  • Cardiac tamponade is rare in idiopathic pericarditis but more common with specific etiologies like malignancy 1

Common Pitfalls to Avoid

  1. Using corticosteroids as first-line therapy - This increases risk of recurrence and should be avoided unless specifically indicated 1

  2. Inadequate treatment duration - Premature discontinuation before symptom and CRP normalization increases recurrence risk 1, 4

  3. Insufficient colchicine duration - Should be continued for 3 months in first episode and 6 months in recurrences 1, 2

  4. Failure to taper NSAIDs/aspirin - Abrupt discontinuation may lead to rebound symptoms 1

  5. Excessive physical activity - Rest is important until inflammation resolves 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.